MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511125188 A) filed by Chandigarh University, Mohali, Punjab, on Dec. 11, 2025, for 'dual-mode blood group testing device featuring biodegradable design and ai analytics.'
Inventor(s) include Sayon Mitra; Dr Amrindra Pal; and Dr. Aman Kataria.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses an AI-powered biodegradable blood group testing kit designed to provide rapid ABO and Rh(D) blood typing without laboratory infrastructure or trained personnel. The kit includes a biodegradable test panel pre-coated with antisera A, B, and D reagents, along with a simple blood collection tool requiring only a finger-prick sample. Results are generated within two minutes through visible agglutination and can be interpreted either manually using an integrated reference guide or automatically using a mobile application that employs artificial intelligence to analyze captured images and minimize interpretation errors. All components of the kit are fully biodegradable and contain an embedded Tulsi seed, enabling the used kit to be planted in soil where it naturally decomposes and germinates within 7-15 days, eliminating biomedical waste. The invention offers a portable, affordable, and environmentally responsible diagnostic solution for emergency care, rural healthcare, education, and widespread field use."
Disclaimer: Curated by HT Syndication.
